Skip to main content
. 2023 Aug 14;9(3):411–427. doi: 10.1007/s41030-023-00238-8

Table 2.

Analysis of combined rT7SS (AM + PM)—ITT population

Variable time point Treatment N Mean (SD) LSM Source p value Treatment difference [95% (CI)]
Baseline MP-AzeFlu 300 25.40 (6.96) 25.08 Treatment 0.6703
Aze 298 24.89 (7.07) 24.61
Flu 299 24.97 (7.33) 24.72
Day 2 to day 7 change from baseline (AM + PM) MP-AzeFlu 300 − 8.33 (7.64) − 8.11
Aze 298 − 5.20 (7.58) − 5.95 MP-AzeFlu vs. Aze  < 0.0001 − 1.73 (− 3.05, − 1.28)
Flu 299 − 6.55(8.01) − 6.24 MP-AzeFlu vs. Flu  < 0.0001 − 1.17 (− 2.76, − 0.99)
Day 2 to day 14 change from baseline (AM + PM) MP-AzeFlu 300 − 11.00 (8.71) − 10.69
Aze 298 − 7.17 (8.87) -8.29 MP-AzeFlu vs. Aze  < 0.0001 − 1.96 (− 3.26, − 1.54)
Flu 299 − 9.77 (9.31) − 9.10 MP-AzeFlu vs. Flu 0.0003 − 0.98 (− 2.44, − 0.73)